e-learning
resources
Monograph
2019
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Mechanisms of lung disease in AATD
Cesare Saltini, Karina Krotova
Source:
Eur Respir Monogr 2019; 85: 52-63
Journal Issue:
a
1
-Antitrypsin Deficiency
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Cesare Saltini, Karina Krotova. Mechanisms of lung disease in AATD. Eur Respir Monogr 2019; 85: 52-63
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Mechanisms of liver disease in AATD
Source: Eur Respir Monogr 2019; 85: 93-104
Year: 2019
Treatment of lung disease in patients with AATD
Source: Eur Respir Monogr 2019; 85: 78-92
Year: 2019
Siphonage lung disease
Source: Virtual Congress 2020 – Respiratory critical care
Year: 2020
Monitoring of CF lung disease
Source: ERS course 2015
Year: 2015
Biomarkers for interstitial lung disease
Source: International Congress 2016 – ME1 Biomarkers for interstitial lung disease
Year: 2016
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Year: 2020
Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Year: 2020
Novel lung function tests in patients with interstitial lung disease (ILD)
Source: International Congress 2016 – Clinical aspects of ILD
Year: 2016
Debate – Controversies in interstitial lung disease
Source: ERS webinar 2021
Access for REGISTERED non-members
Year: 2021
Senotherapies for chronic lung disease
Source: ERS Lung Science Conference 2020
Year: 2020
Aging in lung disease
Source: International Congress 2016 – The future is now: the challenge of ageing in respiratory medicine
Year: 2016
Smoking-induced lung disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-51-8, page=134
Year: 2007
Cellular mechanisms of paediatric lung disease
Source: Virtual Congress 2020 – Paediatric year in review
Year: 2020
Subsequent COPD and lung cancer in patients with autoimmune disease
Source: Eur Respir J 2011; 37: 463
Year: 2011
Scleroderma lung disease
Source: Eur Respir Rev 2013; 22: 6-19
Year: 2013
Prediction of chronic lung disease
Source: Eur Respir J 2003; 22: Suppl. 45, 139s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept